LLY vs UHS
By Alex · Tickerpine
Eli Lilly and Company vs Universal Health Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | UHS |
|---|---|---|
| Price | $1,208.12 | $145.69 |
| Market cap | $1.08T | $8.82B |
| P/E ratio | 42.9 | 6.1 |
| ROE | 107.46% | 21.37% |
| Profit margin | 34.99% | 8.56% |
| Revenue growth | 55.50% | 9.60% |
| Dividend yield | 0.57% | 0.55% |
| Beta | 0.52 | 1.08 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs UHS in plain English
- LLY is the bigger company — about 122.2× the market cap of UHS.
- UHS is cheaper on earnings (P/E 6.1 vs 42.9).
- LLY earns a higher return on equity (107% vs 21%).
- LLY is growing revenue faster (56% vs 10%).
- LLY has the higher dividend yield (0.57% vs 0.55%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
UHS return calculator
See what $1,000 in Universal Health Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.